Related references
Note: Only part of the references are listed.Morphine-induced respiratory depression is independent of β-arrestin2 signalling
Andrea Kliewer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis et al.
SCIENCE SIGNALING (2020)
Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System
Nicolas Massaly et al.
NEURON (2019)
Commonly Used Anesthesia/Euthanasia Methods for Brain Collection Differentially Impact MAPK Activity in Male and Female C57BL/6 Mice
Mee Jung Ko et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kendall L. Mores et al.
FRONTIERS IN PHARMACOLOGY (2019)
Systemic administration of a delta opioid receptor agonist, KNT-127, facilitates extinction learning of fear memory in rats
Azusa Sugiyama et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
An amygdalar neural ensemble that encodes the unpleasantness of pain
Gregory Corder et al.
SCIENCE (2019)
Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects
A. Kliewer et al.
NATURE COMMUNICATIONS (2019)
The delta opioid receptor agonist KNT-127 in the prelimbic medial prefrontal cortex attenuates veratrine-induced anxiety-like behaviors in mice
Akiyoshi Saitoh et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
The novel mu-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
Rob Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Tolerance to high-internalizing opioid receptor agonist is critically mediated by arrestin 2
Ana Vicente-Sanchez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
β-Arrestin-biased β-adrenergic signaling promotes extinction learning of cocaine reward memory
Bing Huang et al.
SCIENCE SIGNALING (2018)
Behavioral Characterization of β-Arrestin 1 Knockout Mice in Anxiety-Like and Alcohol Behaviors
Meridith T. Robins et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2018)
β-Arrestin-biased β-adrenergic signaling promotes extinction learning of cocaine reward memory
Bing Huang et al.
SCIENCE SIGNALING (2018)
Critical Role for Gi/o-Protein Activity in the Dorsal Striatum in the Reduction of Voluntary Alcohol Intake in C57Bl/6 Mice
Meridith T. Robins et al.
FRONTIERS IN PSYCHIATRY (2018)
The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats
C. Austin Zamarripa et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Social support rescues acute stress-induced cognitive impairments by modulating ERK1/2 phosphorylation in adolescent mice
Ji-Woon Kim et al.
SCIENTIFIC REPORTS (2018)
The Basolateral Amygdala Is Essential for Rapid Escape: A Human and Rodent Study
David Terburg et al.
CELL (2018)
Arrestin-2 and arrestin-3 differentially modulate locomotor responses and sensitization to amphetamine
Lilia Zurkovsky et al.
NEUROPHARMACOLOGY (2017)
New Concepts in Dopamine D-2 Receptor Biased Signaling and Implications for Schizophrenia Therapy
Nikhil M. Urs et al.
BIOLOGICAL PSYCHIATRY (2017)
β-Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake
T. Chiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Agonist-Specific Recruitment of Arrestin Isoforms Differentially Modify Delta Opioid Receptor Function
Amynah A. Pradhan et al.
JOURNAL OF NEUROSCIENCE (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain
Yun K. Hahn et al.
NEUROBIOLOGY OF DISEASE (2016)
Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties
Nikhil M. Urs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
Erica M. Richards et al.
PSYCHOPHARMACOLOGY (2016)
Delta opioid receptors expressed in forebrain GABAergic neurons are responsible for SNC80-induced seizures
Paul Chu Sin Chung et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
A Novel Anxiogenic Role for the Delta Opioid Receptor Expressed in GABAergic Forebrain Neurons
Paul Chu Sin Chung et al.
BIOLOGICAL PSYCHIATRY (2015)
From circuits to behaviour in the amygdala
Patricia H. Janak et al.
NATURE (2015)
Neuronal circuits for fear and anxiety
Philip Tovote et al.
NATURE REVIEWS NEUROSCIENCE (2015)
A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks
Eric Erbs et al.
BRAIN STRUCTURE & FUNCTION (2015)
Recent developments in biased agonism
James W. Wisler et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
GPR30 activation decreases anxiety in the open field test but not in the elevated plus maze test in female mice
Divya Anchan et al.
BRAIN AND BEHAVIOR (2014)
BLA to vHPC Inputs Modulate Anxiety-Related Behaviors
Ada C. Felix-Ortiz et al.
NEURON (2013)
δ-Opioid Mechanisms for ADL5747 and ADL5859 Effects in Mice: Analgesia, Locomotion, and Receptor Internalization
Chihiro Nozaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Amygdala circuitry mediating reversible and bidirectional control of anxiety
Kay M. Tye et al.
NATURE (2011)
The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics
Kirsten M. Raehal et al.
NEUROPHARMACOLOGY (2011)
Discovery of β-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy
John A. Allen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Therapeutic potential of β-arrestin- and G protein-biased agonists
Erin J. Whalen et al.
TRENDS IN MOLECULAR MEDICINE (2011)
The delta opioid receptor: an evolving target for the treatment of brain disorders
Amynah A. Pradhan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Dual Efficacy of Delta Opioid Receptor-Selective Ligands for Ethanol Drinking and Anxiety
Richard M. van Rijn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis
Miguel Perez de la Mora et al.
PROGRESS IN NEUROBIOLOGY (2010)
Dorsal hippocampal opioidergic system modulates anxiety-like behaviors in adult male Wistar rats
Jalal Solati et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
Anxiety- and depressive-like responses and c-fos activity in preproenkephalin klockout mice: Oversensitivity hypothesis of enkephalin deficit-induced posttraumatic stress disorder
Jen-Chuang Kung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
The Serotonin-1A Receptor in Anxiety Disorders
Elena Akimova et al.
BIOLOGICAL PSYCHIATRY (2009)
The δ1 Opioid Receptor Is a Heterodimer That Opposes the Actions of the δ2 Receptor on Alcohol Intake
Richard M. van Rijn et al.
BIOLOGICAL PSYCHIATRY (2009)
Beyond extinction: erasing human fear responses and preventing the return of fear
Merel Kindt et al.
NATURE NEUROSCIENCE (2009)
Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression
Denis J. David et al.
NEURON (2009)
Regulation of amygdalar PKA by β-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning
Yuting Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking
Benjamin B. Land et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectornized rat model
Akiyoshi Saitoh et al.
BRAIN RESEARCH (2008)
A β-arrestin 2 signaling complex mediates lithium action on Behavior
Jean-Martin Beaulieu et al.
CELL (2008)
Modulation of voluntary ethanol consumption by beta-arrestin 2
K. Bjork et al.
FASEB JOURNAL (2008)
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain:: Discovery of N,N-diethyl-4-(5-hydroxyspiro-[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)
Bertrand Le Bourdonnec et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Receptor heterodimerization leads to a switch in signaling:: β-arrestin2-mediated ERK activation by μ-δ opioid receptor heterodimers
Raphael Rozenfeld et al.
FASEB JOURNAL (2007)
Genetic correlation between innate alcohol preference and fear-potentiated startle in selected mouse lines
Gustavo D. Barrenha et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
Extinction of auditory fear conditioning requires MAPK/ERK activation in the basolateral amygdala
Cyril Herry et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Kappa opioid receptor activation of p38 MAPK is GRK3-and arrestin-dependent in neurons and astrocytes
Michael R. Bruchas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Delta opioid receptor ligands modulate anxiety-like behaviors in the rat
SA Perrine et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala
M Narita et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Role of the ERK pathway in psychostimulant-induced locomotor sensitization
E Valjent et al.
BMC NEUROSCIENCE (2006)
An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior
JM Beaulieu et al.
CELL (2005)
Transduction of receptor signals by β-arrestins
RJ Leftowitz et al.
SCIENCE (2005)
Morphine side effects in beta-arrestin 2 knockout mice
KM Raehal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Arrestin2 expression selectively increases during neural differentiation
EV Gurevich et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Finding the intracellular signaling pathways affected by mood disorder treatments
JT Coyle et al.
NEURON (2003)
The mouse light/dark box test
M Bourin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety
DL Walker et al.
PSYCHOPHARMACOLOGY (2002)
Seven-transmembrane receptors
KL Pierce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
β-arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation
AK Tohgo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development
EV Gurevich et al.
NEUROSCIENCE (2002)
Role of CRF1 and CRF2 receptors in fear and anxiety
LK Takahashi
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2001)
Direct binding of β-arrestins to two distinct intracellular domains of the δ opioid receptor
B Cen et al.
JOURNAL OF NEUROCHEMISTRY (2001)
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
LM Bohn et al.
NATURE (2000)
The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety
SE File et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Share Paper
